Lisdexamfetamine dimesylate
HealthData.Gov
Updated May 26, 2026
About this dataset
Lisdexamfetamine Dimesylate is a generic prescription medication manufactured by Hikma Pharmaceuticals USA Inc. It's a central nervous system stimulant classified as a DEA Schedule II controlled substance, available in oral capsule form in strengths of 10mg, 20mg, 30mg, 40mg, 50mg, 60mg, and 70mg. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Lisdexamfetamine dimesylate
Access the FDA dataset for Lisdexamfetamine dimesylate — ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025